Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
This report aims to provide a comprehensive presentation of the global market for Radiopharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radiopharmaceuticals. This report contains market size and forecasts of Radiopharmaceuticals in global, including the following market information:
- Global Radiopharmaceuticals Market Revenue, 2018-2023, 2024-2029, ($ millions)
- Global Radiopharmaceuticals Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Radiopharmaceuticals companies in 2022 (%)
The global Radiopharmaceuticals market was valued at US$ 6956.7 million in 2022 and is projected to reach US$ 11660 million by 2029, at a CAGR of 7.7% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The major players in global Radiopharmaceuticals market include Bracco Imaging, Bayer, Mallinckrodt, etc. The top 3 players hold over 40% of global market shares. North America and Europe are main markets, they occupy over 70% of the global market. Diagnostic Radioisotopes is the main type, with a share about 90%. Oncology is the key application, which hold over 60% shares.
We surveyed the Radiopharmaceuticals manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Radiopharmaceuticals Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Radiopharmaceuticals Market Segment Percentages, by Type, 2022 (%)
- Diagnostic Radioisotopes
- Therapeutic Radioisotopes
Global Radiopharmaceuticals Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Radiopharmaceuticals Market Segment Percentages, by Application, 2022 (%)
- Oncology
- Cardiology
- Other
Global Radiopharmaceuticals Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Radiopharmaceuticals Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Radiopharmaceuticals revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Radiopharmaceuticals revenues share in global market, 2022 (%)
- Key companies Radiopharmaceuticals sales in global market, 2018-2023 (Estimated), (K Units)
- Key companies Radiopharmaceuticals sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Bracco Imaging
- Bayer
- Mallinckrodt
- Nordion
- Triad Isotopes
- Lantheus
- IBA Group
- GE Healthcare
- China Isotope & Radiation
- Jubilant Pharma
- Eli Lilly
- Advanced Accelerator Applications
- SIEMENS
- Dongcheng
- Navidea
- Outline of Major Chapters:
- Chapter 1: Introduces the definition of Radiopharmaceuticals, market overview.
- Chapter 2: Global Radiopharmaceuticals market size in revenue and volume.
- Chapter 3: Detailed analysis of Radiopharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Radiopharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: Global Radiopharmaceuticals capacity by region & country.
- Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
